← Назад

Vogt-Koyanagi-Harada disease

ORPHA:3437DiseaseMultigenic/multifactorialAll ages

Ассоциированные гены (3)

HLA-DRB1
major histocompatibility complex, class II, DR beta 1
Major susceptibility factor in
OMIM: 142857
FAS
Fas cell surface death receptor
Major susceptibility factor in
OMIM: 134637
PTPN22
protein tyrosine phosphatase non-receptor type 22
Major susceptibility factor in
OMIM: 600716

Фенотипы (37)

Очень частый (80–99%)10
HP:0000499Abnormal eyelash morphology
HP:0000534Abnormal eyebrow morphology
HP:0001045Vitiligo
HP:0001053Hypopigmented skin patches
HP:0002209Sparse scalp hair
HP:0002216Premature graying of hair
HP:0002290Poliosis
HP:0002315Headache
HP:0012229CSF pleocytosis
HP:0100543Cognitive impairment
Частый (30–79%)15
HP:0000360Tinnitus
HP:0000407Sensorineural hearing impairment
HP:0000505Visual impairment
HP:0000518Cataract
HP:0000541Retinal detachment
HP:0000554Uveitis
HP:0000622Blurred vision
HP:0001094Iridocyclitis
HP:0004322Short stature
HP:0007787Posterior subcapsular cataract
HP:0007906Ocular hypertension
HP:0020120Retinal nerve fiber edema
HP:0030953Conjunctival hyperemia
HP:0031179Nuchal rigidity
HP:0040030Chorioretinal hypopigmentation
Периодический (5–29%)12
HP:0000501Glaucoma
HP:0000613Photophobia
HP:0001596Alopecia
HP:0001945Fever
HP:0002018Nausea
HP:0002321Vertigo
HP:0002381Aphasia
HP:0009926Epiphora
HP:0011484Posterior synechiae of the anterior chamber
HP:0025341Corneal keratic precipitates
HP:0100809Scalp tenderness
HP:6000710Dalen Fuchs nodules

Эпидемиология (2)

Point prevalence
Unknown
Worldwide
Annual incidence
1-9 / 1 000 000
United States

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы